Page 4389

Cardano (ADA)

Analysts Say New Cardano Alternative Now at $0.1 Could Repeat ADA’s 63000% annual Gains Seen in 2021

By • February 2, 2024 •
Stellar (XLM)

Stellar (XLM) Project ‘Refugee’ Receives International Association for Trusted Blockchain Applications Award

By • February 2, 2024 •
RIPPLE (XRP)

Binance Freezes $4.2M In Stolen XRP Linked To $120M Hack

By • February 2, 2024 •
RIPPLE (XRP)

XRP and Cardano navigate price headwinds as a new cryptocurrency soars past the 10 million mark

By • February 2, 2024 •
RIPPLE (XRP)

XRP Coin Slumps Amid Online Exploit News – Can It Regain Momentum for a Pump?

By • February 2, 2024 •
ETHEREUM (ETH)

Can Ethereum (ETH) Reach the Coveted $10,000 Mark by 2030?

By • February 2, 2024 •
ETHEREUM (ETH)

Prediction: Ethereum Will Reach $10,000 in 2030

By • February 2, 2024 •
ETHEREUM (ETH)

Is Market Ready For Ethereum ETF? Approval Uncertainty Keeps Traders Bullish On Bitcoin, Says Report

By • February 2, 2024 •
BITCOIN (BTC)

Bitcoin’s Path to $2.3 Million: Unpacking ARK Invest’s Bold Forecast

By • February 2, 2024 •
BITCOIN (BTC)

Passing $300 million, BlackRock bitcoin ETF volume beats Grayscale’s for first time

By • February 2, 2024 •
BITCOIN (BTC)

ETF managers talk Bitcoin after SEC approval

By • February 2, 2024 •
BITCOIN (BTC)

Bitcoin ETF Provider Valkyrie Adds BitGo as Second Custodian in Risk Mitigation Move

By • February 2, 2024 •
BITCOIN (BTC)

Bitcoin price today: BTC is up 2.43%

By • February 2, 2024 •
BITCOIN (BTC)

Bitcoin Ordinals sales dip 61% in January, halving sparks hope

By • February 2, 2024 •
BITCOIN (BTC)

Bitcoin Tops $43,000 Following Jobs Data; Pyth Network Emerges As Top Gainer

By • February 2, 2024 •
Decred (DCR)

PatientPoint Becomes First Point-of-Care Publisher to Earn Media Rating Council Accreditation

By • February 2, 2024 •
Decred (DCR)

Australian shares hit 2-week high on banking boost

By • February 2, 2024 •
Decred (DCR)

China stocks struggle despite cabinet’s pledge to stabilise market

By • February 2, 2024 •
Decred (DCR)

Bold Therapeutics Announces Positive Phase 2 Safety and Efficacy Results for BOLD-100 in Advanced Metastatic Colorectal Cancer at ASCO GI 2024

By • February 2, 2024 •
Cardano (ADA)

Cardano (ADA) and Dogecoin (DOGE) Experience Dip in Momentum – NuggetRush (NUGX) Soar in Ongoing Presale

By • February 2, 2024 •
Tether (USDT)

JPMorgan Warns of Tether’s Dominance and Regulatory Risks to Crypto

By • February 2, 2024 •